NextNRG Hit With Second Nasdaq Deficiency — $35M MVLS Notice, Panel Decision Pending
NXXT is trading near its 52-week low of $0.5 (2.9% above the low) on light trading volume (0.2× avg).
Summary
NextNRG received a Nasdaq notice that its market value of listed securities fell below the $35 million minimum and that it also fails the equity and net income alternatives, giving it until April 19, 2027 to comply while a separate delisting appeal awaits the Hearings Panel's decision.
Key Events · Legal and Risk Events · NXXT
-
Nasdaq MVLS Deficiency Notice Received
On October 21, 2026 Nasdaq notified NextNRG that its market value of listed securities was below the $35,000,000 minimum for the 30 consecutive business days from September 9, 2026 through October 20, 2026.
-
No Alternative Listing Standard Met
The notice also states the company does not meet the $2,500,000 stockholders' equity standard or the $500,000 net income standard, so all three Capital Market continued-listing paths under Rule 5550(b) are currently failed.
-
180-Day Cure Window to April 19, 2027
NextNRG has 180 calendar days, until April 19, 2027, to regain the $35,000,000 MVLS threshold, generally requiring ten consecutive business days above it, or to demonstrate $2,500,000 of stockholders' equity.
-
Delisting Appeal Decision Still Outstanding
The bid-price delisting appeal was heard by the Nasdaq Hearings Panel on October 22, 2026 and no final written decision has been issued; the Panel may also weigh the new MVLS noncompliance.
Analysis · NXXT · Trade & Services
NextNRG now fails Nasdaq's market value standard as well as the bid price rule it was already appealing. Its listed securities stayed below the $35 million minimum for the 30 business days through October 20, 2026, and the company also misses the alternative tests — $2.5 million in stockholders' equity or $500,000 of net income — leaving no easy escape hatch. It has until April 19, 2027 to cure the MVLS gap, but the more immediate question is the Hearings Panel's ruling on the earlier bid-price delisting, which was argued October 22, 2026 and is still undecided. A delisting would cut liquidity, shut the company out of shelf-registered equity sales and undercut its ability to issue stock incentives — a serious problem for a company already flagged with going-concern doubt and reliant on toxic preferred financing.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 45.6% of the 241 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NXXT was trading at $0.51 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $8.7M. The 52-week trading range was $0.50 to $22.20. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.